Stock AMBIT BIOSCIENCES CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Ambit Biosciences Corp

Equities

US02318X1000

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Ambit Biosciences Corp
2014 DAIICHI SANKYO : Japan's Daiichi Sankyo to acquire US biopharma Ambit Biosciences RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ambit Biosciences : Daiichi Sankyo and Ambit Announce Results of Tender Offer
PR
Ambit Biosciences : Announces Expiration of Hart-Scott-Rodino Waiting Period
PR
Ambit Biosciences : Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation
PR
Ambit Biosciences : Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR
Ambit Biosciences : Ryan & Maniskas, LLP : Announces Investigation of Ambit Biosciences Corporation
PR
Ambit Biosciences : Law Offices of Howard G. Smith : Announces Investigation of Ambit Biosciences Corporation
BU
Ambit Biosciences : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Ambit Biosciences Corporation Stockholders
BU
DAIICHI SANKYO : Japan's Daiichi Sankyo to acquire US biopharma Ambit Biosciences
RE
Ambit Biosciences : Announces Participation At Baird 2014 Health Care Conference
PR
Ambit Biosciences : Announces Second Quarter 2014 Operating Results
PR
Ambit Biosciences : To Announce Second Quarter 2014 Financial Results
PR
Ambit Biosciences : Announces Changes To Board Of Directors
PR
Ambit Biosciences : Announces Presentation of Data from Clinical Investigations of Quizartinib at the 2014 Annual Meeting of The American Society Of Clinical Oncology
PU
Ambit Biosciences : Announces Participation At Jefferies 2014 Global Healthcare Conference
PR
Ambit Biosciences : Announces Participation At Deutsche Bank 39th Annual Healthcare Conference
PR
Ambit Biosciences : Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
PU
Ambit Biosciences : to Announce First Quarter 2014 Financial Results
PR
Ambit Biosciences : Announces Initiation Of Quizartinib QUANTUM-R Phase 3 Trial
PR
Ambit Biosciences : Announces Initiation Of Phase 2 Cohort In MD Anderson Sponsored Study Of Quizartinib In AML And High Risk MDS
PR
Ambit Biosciences : Announces Fourth Quarter And Full-Year 2013 Operating Results
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Ambit Biosciences Corp